论文部分内容阅读
近来尽管发展了胎脑移植、多巴胺受体激动剂等治疗帕金森病,然而L-多巴和多巴胺脱羧酶抑制剂的复方品仍然是主要的、不可替代的药品。森纳梅脱(神力酶、国产Sinemet)就是其中之一。本文采用广东利民制药厂研制的森纳梅脱治疗帕金森病及观察脑脊液(CSF)单胺类物质变化。
Recently, despite the development of fetal brain transplantation, dopamine receptor agonists and other treatment of Parkinson’s disease, however, L-dopa and dopamine decarboxylase inhibitor compound is still the main, irreplaceable drugs. Senna Mei off (divine enzyme, domestic Sinemet) is one of them. In this paper, the Limin Pharmaceutical Factory in Guangdong developed Sennapreol treatment of Parkinson’s disease and observation of cerebrospinal fluid (CSF) monoamine substances changes.